Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4706598> ?p ?o }
Showing triples 1 to 71 of
71
with 100 triples per page.
- Q4706598 description "British biochemist".
- Q4706598 description "British biochemist".
- Q4706598 subject Q5312304.
- Q4706598 subject Q6647427.
- Q4706598 subject Q6822920.
- Q4706598 subject Q6999066.
- Q4706598 subject Q7115173.
- Q4706598 subject Q8219093.
- Q4706598 subject Q8315228.
- Q4706598 subject Q8415969.
- Q4706598 subject Q8921573.
- Q4706598 abstract "Alan Hutchison Fairlamb, CBE, FRSE, FLS, FMedSci, FSB (born 30 April 1947, Newcastle upon Tyne, England) is a Wellcome Trust Principal Research Fellow and Professor of Biochemistry in the Division of Biological Chemistry and Drug Discovery at the University of Dundee, Scotland. From 2006-2011 he was a member of the Scientific and Technical Advisory Committee of the Special Programme for Research and Training in Tropical Diseases (TDR) -- an independent global programme of scientific collaboration co-sponsored by UNICEF, UNDP, the World Bank and WHO. Currently he is a member of the governing board of the Tres Cantos Open Lab Foundation, whose aim is to accelerate the discovery and development of medicines to tackle diseases of the developing world in an open collaborative manner.Professor Alan Fairlamb, and his team study the protozoan parasites causing three different diseases - sleeping sickness, Chagas disease and leishmaniasis. He was one of the 250 scientists involved in the genome sequencing of these parasites.In 1985, Alan Fairlamb discovered a unique thiol compound present in these parasites, and named it trypanothione. This thiol metabolite is quite different from its human equivalent, glutathione. Trypanothione allows the parasites to fend off free radicals and other toxic oxidants produced by the immune system of the infected patient, and was shown to be vital for parasite survival and virulence. For instance, antimonials neutralize the Leishmania parasite’s antioxidant defence system, allowing the patient to clear the infection. Studies on the effect of drugs on trypanothione metabolism resulted in the discovery that fexinidzole is a potential oral treatment for visceral leishmaniasis.Since 2006, Alan Fairlamb and Mike Ferguson have been co-directors of the Drug Discovery Unit at the University of Dundee. The new centre, opened in 2005, has facilities for high-throughput screening and medicinal chemistry. These will take the drug discovery/development process further than any other UK university, to a stage where pharmaceutical companies will have sufficient data to move into the production stage.".
- Q4706598 birthDate "1947-04-30".
- Q4706598 birthYear "1947".
- Q4706598 thumbnail TSH.png?width=300.
- Q4706598 wikiPageExternalLink %7Eahfairla.
- Q4706598 wikiPageWikiLink Q116907.
- Q4706598 wikiPageWikiLink Q117467.
- Q4706598 wikiPageWikiLink Q1249005.
- Q4706598 wikiPageWikiLink Q1425428.
- Q4706598 wikiPageWikiLink Q14420.
- Q4706598 wikiPageWikiLink Q161718.
- Q4706598 wikiPageWikiLink Q185056.
- Q4706598 wikiPageWikiLink Q186517.
- Q4706598 wikiPageWikiLink Q187689.
- Q4706598 wikiPageWikiLink Q203133.
- Q4706598 wikiPageWikiLink Q2068526.
- Q4706598 wikiPageWikiLink Q21.
- Q4706598 wikiPageWikiLink Q220410.
- Q4706598 wikiPageWikiLink Q243455.
- Q4706598 wikiPageWikiLink Q326276.
- Q4706598 wikiPageWikiLink Q331283.
- Q4706598 wikiPageWikiLink Q4671486.
- Q4706598 wikiPageWikiLink Q524818.
- Q4706598 wikiPageWikiLink Q5312304.
- Q4706598 wikiPageWikiLink Q626251.
- Q4706598 wikiPageWikiLink Q649558.
- Q4706598 wikiPageWikiLink Q6647427.
- Q4706598 wikiPageWikiLink Q6822920.
- Q4706598 wikiPageWikiLink Q6999066.
- Q4706598 wikiPageWikiLink Q7094.
- Q4706598 wikiPageWikiLink Q7115173.
- Q4706598 wikiPageWikiLink Q7164.
- Q4706598 wikiPageWikiLink Q740308.
- Q4706598 wikiPageWikiLink Q7552397.
- Q4706598 wikiPageWikiLink Q7817.
- Q4706598 wikiPageWikiLink Q7848584.
- Q4706598 wikiPageWikiLink Q8219093.
- Q4706598 wikiPageWikiLink Q8315228.
- Q4706598 wikiPageWikiLink Q8415969.
- Q4706598 wikiPageWikiLink Q867447.
- Q4706598 wikiPageWikiLink Q8921573.
- Q4706598 dateOfBirth "1947-04-30".
- Q4706598 name "Fairlamb, Alan".
- Q4706598 shortDescription "British biochemist".
- Q4706598 type Person.
- Q4706598 type Agent.
- Q4706598 type Person.
- Q4706598 type Agent.
- Q4706598 type NaturalPerson.
- Q4706598 type Thing.
- Q4706598 type Q215627.
- Q4706598 type Q5.
- Q4706598 type Person.
- Q4706598 comment "Alan Hutchison Fairlamb, CBE, FRSE, FLS, FMedSci, FSB (born 30 April 1947, Newcastle upon Tyne, England) is a Wellcome Trust Principal Research Fellow and Professor of Biochemistry in the Division of Biological Chemistry and Drug Discovery at the University of Dundee, Scotland.".
- Q4706598 label "Alan Fairlamb".
- Q4706598 depiction TSH.png.
- Q4706598 givenName "Alan".
- Q4706598 name "Alan Fairlamb".
- Q4706598 name "Fairlamb, Alan".
- Q4706598 surname "Fairlamb".